[1] |
ZHANG X, ZHANG W, CHEN S. Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic[J]. Lancet, 2022, 399(10340):2011-2012.
DOI
URL
|
[2] |
CALLAWAY E, LEDFORD H. How bad is omicron? What scientists know so far[J]. Nature, 2021, 600(7888):197-199.
DOI
|
[3] |
蒿叶霞, 颜新生, 杨荟荟, 等. 新型冠状病毒病毒载量预测COVID-19疾病严重程度的价值[J]. 检验医学, 2020, 35(11):1140-1142.
|
[4] |
LA SCOLA B, LE BIDEAU M, ANDREANI J, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards[J]. Eur J Clin Microbiol Infect Dis, 2020, 39(6):1059-1061.
DOI
|
[5] |
中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第八版)[J]. 中华临床感染病杂志, 2020, 13(5):321-328.
|
[6] |
TRUNFIO M, VENUTI F, ALLADIO F, et al. Diagnostic SARS-CoV-2 cycle threshold value predicts disease severity,survival,and six-month sequelae in COVID-19 symptomatic patients[J]. Viruses, 2021, 13(2):281.
DOI
URL
|
[7] |
MILLER E H, ZUCKER J, CASTOR D, et al. Pretest symptom duration and cycle threshold values for severe acute respiratory syndrome coronavirus 2 reverse-transcription polymerase chain reaction predict coronavirus disease 2019 mortality[J]. Open Forum Infect Dis, 2021, 8(2):ofab003.
DOI
URL
|
[8] |
ONG S W X, CHIEW C J, ANG L W, et al. Clinical and virological features of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)variants of concern:a retrospective cohort study comparing B.1.1.7(Alpha),B.1.351(Beta),and B. 1.617.2(Delta)[J]. Clin Infect Dis, 2022, 75(1):e1128-e1136.
DOI
URL
|
[9] |
YAO Y, WANG H, LIU Z. Expression of ACE2 in airways:implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases[J]. Clin Exp Allergy, 2020, 50(12):1313-1324.
DOI
URL
|
[10] |
LIU Y, YAN L, WAN L, et al. Viral dynamics in mild and severe cases of COVID-19[J]. Lancet Infect Dis, 2020, 20(6):656-657.
DOI
PMID
|
[11] |
张影, 李晓鹤, 陈凤, 等. 新型冠状病毒德尔塔和奥密克戎变异株感染患者的临床特征分析[J]. 新发传染病电子杂志, 2022, 7(3):22-26.
DOI
|
[12] |
YANG J, WU K, DING A, et al. Clinical characteristics,treatment,and prognosis of 74 2019 novel coronavirus disease patients in Hefei[J]. Medicine, 2021, 100(21):e25645.
DOI
URL
|
[13] |
LIU Y, YANG Y, ZHANG C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury[J]. Sci China Life Sci, 2020, 63(3):364-374.
DOI
PMID
|
[14] |
CHEN W, XIAO Q, FANG Z, et al. Correlation analysis between the viral load and the progression of COVID-19[J]. Comput Math Methods Med, 2021, 2021:9926249.
|
[15] |
SHI F, WU T, ZHU X, et al. Association of viral load with serum biomakers among COVID-19 cases[J]. Virology, 2020, 546:122-126.
DOI
PMID
|
[16] |
QIN C, ZHOU L, HU Z, et al. Dysregulation of immune response in patients with coronavirus 2019(COVID-19)in Wuhan,China[J]. Clin Infect Dis,2020, 71(15):762-768.
DOI
URL
|